Effect of some monoamine oxidase inhibitors on deamination of biogenic monoamines by rat liver mitochondrial monoamine oxidase.
D000470:Alkaloids; D000818:Animals; D003956:Dialysis; D004298:Dopamine / Q000378:metabolism*; D066298:In Vitro Techniques; D007520:Isocarboxazid / Q000494:pharmacology*; D008099:Liver / Q000201:enzymology*; D008928:Mitochondria / Q000201:enzymology*; D008995:Monoamine Oxidase / Q000378:metabolism*; D010293:Pargyline / Q000494:pharmacology*; D010624:Phenelzine / Q000494:pharmacology*; D011804:Quinolines; D051381:Rats; D012701:Serotonin / Q000378:metabolism*; D014439:Tyramine / Q000378:metabolism*
D000470:Alkaloids; D011804:Quinolines; D012701:Serotonin; D007520:Isocarboxazid; D010293:Pargyline; D008995:Monoamine Oxidase; D010624:Phenelzine; D004298:Dopamine; D014439:Tyramine